P06 OFATUMUMAB FOR B CELL DEPLETION THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ARE INTOLERANT OF RITUXIMAB

P06 OFATUMUMAB FOR B CELL DEPLETION THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ARE INTOLERANT OF RITUXIMAB

Bibliographic Details
Main Authors:	S. McAdoo, S. Masoud, R. Bedi, T. Cairns, L. Lightstone
Format:	Article
Language:	English
Published:	Elsevier 2016-11-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024916300912

Similar Items

Case Report: Ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocytopathy
by: Shugang Cao, et al.
Published: (2023-05-01)

Rituximab in the management of systemic lupus erythematosus
by: Adrian Levitsky, et al.
Published: (2013-06-01)

Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
by: López Longo J, et al.
Published: (2010-11-01)

P148 Comparison of cyclophosphamide and rituximab in the treatment of severe systemic lupus erythematosus
by: László Kovács, et al.
Published: (2024-03-01)

Use of rituximab in systemic lupus erythematosus in children: a review
by: A. N. Arefyeva
Published: (2019-11-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus
by: Didem Atay, et al.
Published: (2012-03-01)

Rituximab in the treatment of extensive and refractory subacute cutaneous lupus erythematosus
by: Mariana Álvares Penha, et al.
Published: (2018-06-01)

Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus
by: Carreño L, et al.
Published: (2010-11-01)

Early addition of rituximab in the management of myositis associated with systemic lupus erythematosus
by: Mervat E Behiry, et al.
Published: (2019-01-01)

Steroid-resistant autoimmune thrombocytopenia in systemic lupus erythematosus treated with rituximab
by: Vasudha V Sardesai, et al.
Published: (2015-01-01)

Refractory Orbital Myositis in Systemic Lupus Erythematosus - A Role for Rituximab
by: Joana Rodrigues Morais, et al.
Published: (2021-12-01)

Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysis
by: Ashleigh Hennessey, et al.
Published: (2019-08-01)

P164 Rituximab intervention in management of thrombocytopenia in patients with systemic lupus erythematosus: a single center experience
by: Serdal Ugurlu, et al.
Published: (2024-03-01)

Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab
by: M É Tsanian, et al.
Published: (2013-05-01)

Vesiculobullous disease with Cutaneous Systemic Lupus Erythematosus Treated by Rituximab: A case report
by: Wigdan Mohammed Niamat Alla, et al.
Published: (2021-10-01)

Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus
by: Ting-Wei Lin, et al.
Published: (2024-01-01)

Experience in Rituximab Administration in Children with Systemic Lupus Erythematosus: a Retrospective Study of the Case Series
by: Mikhail M. Kostik, et al.
Published: (2016-08-01)

Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity
by: Francesca Faustini, et al.
Published: (2022-04-01)

Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents
by: Leanna M. Wise, et al.
Published: (2020-06-01)

Rituximab induced acute thrombocytopenia in a patient with systemic lupus erythematosus: a case report
by: Jevon Yudhishdran, et al.
Published: (2021-07-01)

Response to rituximab in a refractory case of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus
by: Niaz Faraz, et al.
Published: (2010-01-01)

Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab
by: Kazuya Abe, et al.
Published: (2019-10-01)

EFFICACY AND SAFETY OF RITUXIMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A RETROSPECTIVE STUDY OF THE CASE SERIES
by: Ekaterina I. Alexeeva, et al.
Published: (2016-11-01)

Refractory Bullous Systemic Lupus Erythematosus Successfully Treated with Rituximab: A Case Report and Literature Review
by: Ratanapokasatit Y, et al.
Published: (2023-04-01)

LP-190 Successful treatment of rituximab and bortezomib in refractory systemic lupus erythematosus: a case report
by: Chen Chen, et al.
Published: (2023-07-01)

Lupus nephritis, pregnancy and rituximab
by: Enrique Dorado, et al.
Published: (2017-04-01)

Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue Hydroxychloroquine
by: Z. Aouhab, et al.
Published: (2019-11-01)

Relationship of T regulatory cells content, activity and serum autoantibodies level in patients with systemic lupus erythematosus receiving rituximab
by: A V Torgashina
Published: (2009-04-01)

RITUXIMAB TREATMENT EFFICACY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS REFRACTORY TO STANDARD THERAPY IN THE LONG-TERM FOLLOW-UP
by: M. E. Tsanyan, et al.
Published: (2014-06-01)

Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature
by: Chelsea DeCoste, et al.
Published: (2021-01-01)

Successful Treatment with Rituximab in a Patient with Castleman′s Disease Complicated by Systemic Lupus Erythematosus and Severe Autoimmune Thrombocytopenia
by: Lu Zhang, et al.
Published: (2015-01-01)

UK experience of Ofatumumab in refractory B-CLL
by: Varghese, A, et al.
Published: (2011)

Role of ofatumumab in treatment of chronic lymphocytic leukemia
by: Veliz M, et al.
Published: (2011-05-01)

Refractory pemphigus vulgaris successfully treated with ofatumumab
by: Daniel M. Klufas, MD, et al.
Published: (2020-08-01)

What Do Reference Librarians Do Now?
by: Monty L. McAdoo
Published: (2022-09-01)

Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature
by: Josefina Longeri Contreras, et al.
Published: (2021-05-01)

P53 Multimorbidity in systemic lupus erythematosus
by: Pavel Horak, et al.
Published: (2024-03-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Rituximab for treatment of severe lupus nephritis
by: Baskin E, et al.
Published: (2008-09-01)